These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12036912)

  • 1. Recessive transmission of a multiple endocrine neoplasia syndrome in the rat.
    Fritz A; Walch A; Piotrowska K; Rosemann M; Schäffer E; Weber K; Timper A; Wildner G; Graw J; Höfler H; Atkinson MJ
    Cancer Res; 2002 Jun; 62(11):3048-51. PubMed ID: 12036912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial neuroendocrine tumors as a model of hereditary cancer.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1997 Jan; 9(1):45-54. PubMed ID: 9090493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
    Eng C; Mulligan LM
    Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
    Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart HF; Ritter MM; Hampel R; Klempa J; Scholz GH; Raue F
    J Clin Endocrinol Metab; 1996 May; 81(5):1780-3. PubMed ID: 8626834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.
    Hansford JR; Mulligan LM
    J Med Genet; 2000 Nov; 37(11):817-27. PubMed ID: 11073534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple endocrine neoplasia].
    Takami H; Ikeda Y; Kameyama K
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):508-11. PubMed ID: 11977533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
    Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
    Stratakis CA
    J Endocrinol Invest; 2001 May; 24(5):370-83. PubMed ID: 11407658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of multiple endocrine neoplasia.
    Wiedemann T; Pellegata NS
    Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
    Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
    Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
    Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H; Dou S; Chi D; Carlson KM; Toshima K; Lairmore TC; Howe JR; Moley JF; Goodfellow P; Wells SA
    Hum Mol Genet; 1993 Jul; 2(7):851-6. PubMed ID: 8103403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.